Focused on therapies for endocrine and oncologic conditions, this biotech reported significant insider selling in its latest ...
This clinical-stage biotech developing metabolic therapies reported a notable insider sale amid a challenging year for its ...
The procedure is based around dynamic optical contrast microscopy (DOCI), a technique in development at UCLA since 2016. It ...
6don MSN
Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
Direct Meds Reviews Prescription Access Pathways As New GLP-1 Formats Expand. LegitScript-certified telehealth platform ...
StockStory.org on MSN
Branded pharmaceuticals stocks Q3 results: Benchmarking Royalty Pharma (NASDAQ:RPRX)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
TRT Australia now offers telehealth services to prioritise depression treatment for men with low testosterone. The clinic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback